[HTML][HTML] What non-pharmacological treatments do people with polymyalgia rheumatica try: results from the PMR Cohort Study
J Weddell, SL Hider, CD Mallen, S Muller - Rheumatology International, 2022 - Springer
Polymyalgia rheumatica (PMR) is common. The mainstay of treatment, glucocorticoids, are
associated with significant adverse effects and many patients remain on high doses for a …
associated with significant adverse effects and many patients remain on high doses for a …
[HTML][HTML] What non-pharmacological treatments do people with polymyalgia rheumatica try: results from the PMR Cohort Study
J Weddell, SL Hider, CD Mallen… - Rheumatology …, 2022 - ncbi.nlm.nih.gov
Polymyalgia rheumatica (PMR) is common. The mainstay of treatment, glucocorticoids, are
associated with significant adverse effects and many patients remain on high doses for a …
associated with significant adverse effects and many patients remain on high doses for a …
What non-pharmacological treatments do people with polymyalgia rheumatica try: results from the PMR Cohort Study
J Weddell, SL Hider, CD Mallen… - Rheumatology …, 2022 - pubmed.ncbi.nlm.nih.gov
Polymyalgia rheumatica (PMR) is common. The mainstay of treatment, glucocorticoids, are
associated with significant adverse effects and many patients remain on high doses for a …
associated with significant adverse effects and many patients remain on high doses for a …
What non-pharmacological treatments do people with polymyalgia rheumatica try: results from the PMR Cohort Study.
J Weddell, SL Hider, CD Mallen… - Rheumatology …, 2022 - search.ebscohost.com
Polymyalgia rheumatica (PMR) is common. The mainstay of treatment, glucocorticoids, are
associated with significant adverse effects and many patients remain on high doses for a …
associated with significant adverse effects and many patients remain on high doses for a …
What non-pharmacological treatments do people with polymyalgia rheumatica try: results from the PMR Cohort Study.
J Weddell, SL Hider, CD Mallen… - Rheumatology …, 2021 - europepmc.org
Polymyalgia rheumatica (PMR) is common. The mainstay of treatment, glucocorticoids, are
associated with significant adverse effects and many patients remain on high doses for a …
associated with significant adverse effects and many patients remain on high doses for a …
What non‑pharmacological treatments do people with polymyalgia rheumatica try: results from the PMR Cohort Study
J Weddell, SL Hider, CD Mallen, S Muller - 2021 - keele-repository.worktribe.com
Polymyalgia rheumatica (PMR) is common. The mainstay of treatment, glucocorticoids, are
associated with significant adverse effects and many patients remain on high doses for a …
associated with significant adverse effects and many patients remain on high doses for a …
What non-pharmacological treatments do people with polymyalgia rheumatica try: results from the PMR Cohort Study
W Jake, SL Hider, CD Mallen… - Rheumatology …, 2022 - search.proquest.com
Polymyalgia rheumatica (PMR) is common. The mainstay of treatment, glucocorticoids, are
associated with significant adverse effects and many patients remain on high doses for a …
associated with significant adverse effects and many patients remain on high doses for a …
[PDF][PDF] What non‑pharmacological treatments do people with polymyalgia rheumatica try: results from the PMR Cohort Study
J Weddell, SL Hider, CD Mallen, S Muller - 2021 - keele-repository.worktribe.com